Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Molecular Endocrinology

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/MEND.15.6.0664PMID 11376113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGFp Signals through a Heteromeric Protein Kinase Receptor Complex

  2003influential reference
• The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.

  2001cited by this paper
• Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.

  2000cited by this paper
• naked cuticle encodes an inducible antagonist of Wnt signalling

  2000cited by this paper
• Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner

  2000cited by this paper
• Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.

  2000influential reference
• Smad6 Is a Smad1/5-induced Smad Inhibitor

  2000cited by this paper
• Expression of sprouty2 during early development of the chick embryo is coincident with known sites of FGF signalling.

  2000cited by this paper
• Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of beta-catenin.

  2000cited by this paper
• Regulation of Smad activity.

  2000cited by this paper
• The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb.

  2000cited by this paper
• Müllerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism*

  2000cited by this paper
• Transcriptional control by the TGF‐β/Smad signaling system

  2000cited by this paper
• Roles of BMP signaling and Nkx2.5 in patterning at the chick midgut-foregut boundary.

  2000cited by this paper
• Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites.

  2000cited by this paper
• Paracrine-mediated apoptosis in reproductive tract development.

  1999cited by this paper
• Müllerian-Inhibiting Substance Type II Receptor Expression and Function in Purified Rat Leydig Cells.

  1999cited by this paper
• The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo.

  1999cited by this paper
• Smad1 and Smad5 have distinct roles during dorsoventral patterning of the zebrafish embryo

  1999cited by this paper
• Female development in mammals is regulated by Wnt-4 signalling

  1999cited by this paper
• Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.

  1999cited by this paper
• Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.

  1999cited by this paper
• Regulation of Smad7 Promoter by Direct Association with Smad3 and Smad4*

  1999cited by this paper
• Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors*

  1999cited by this paper
• Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis.

  1999cited by this paper
• TGF- SIGNAL TRANSDUCTION

  1998cited by this paper
• Twin peaks: Spitz and Argos star in patterning of the Drosophila egg.

  1998cited by this paper
• Induction of Smad6 mRNA by bone morphogenetic proteins.

  1998cited by this paper
• The role of anti-Müllerian hormone in gonadal development.

  1998cited by this paper
• Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members.

  1998cited by this paper
• Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription.

  1998cited by this paper
• New insights into mullerian inhibiting substance and its mechanism of action.

  1998cited by this paper
• Receptors for anti-müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation.

  1998cited by this paper
• Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2*

  1998influential reference
• Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis.

  1998cited by this paper
• Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription

  1998cited by this paper
• The Tlx-2 homeobox gene is a downstream target of BMP signalling and is required for mouse mesoderm development.

  1998cited by this paper
• Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats.

  1998cited by this paper
• The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes.

  1998cited by this paper
• Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene

  1998influential reference
• Müllerian Inhibiting Substance Inhibits Branching Morphogenesis and Induces Apoptosis in Fetal Rat Lung.

  1997cited by this paper
• Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development.

  1997cited by this paper
• Smad8 mediates the signaling of the receptor serine kinase

  1997cited by this paper
• Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase.

  1997cited by this paper
• Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling.

  1997cited by this paper
• The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling

  1997cited by this paper
• The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation.

  1997cited by this paper
• Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.

  1997cited by this paper
• The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.

  1997cited by this paper
• Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

  1997cited by this paper
• Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.

  1997cited by this paper
• The Xvent-2 homeobox gene is part of the BMP-4 signalling pathway controlling [correction of controling] dorsoventral patterning of Xenopus mesoderm.

  1996cited by this paper
• Growth differentiation factor-9 is required during early ovarian folliculogenesis

  1996cited by this paper
• A human Mad protein acting as a BMP-regulated transcriptional activator

  1996cited by this paper
• Sertoli cell signaling by Desert hedgehog regulates the male germline.

  1996cited by this paper
• Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.

  1996cited by this paper
• The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse.

  1996cited by this paper
• Developmental expression of a candidate müllerian inhibiting substance type II receptor.

  1996cited by this paper
• The Xvent-2 homeobox gene is part of the BMP-4 signalling pathway controling dorsoventral patterning of Xenopus mesoderm

  1996cited by this paper
• Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.

  1995cited by this paper
• Ontogeny of reproductive abnormalities induced by deregulation of anti-müllerian hormone expression in transgenic mice.

  1995cited by this paper
• A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.

  1995cited by this paper
• Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.

  1994cited by this paper
• Müllerian-inhibiting substance function during mammalian sexual development.

  1994cited by this paper
• A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo.

  1994cited by this paper
• The in vivo roles of müllerian-inhibiting substance.

  1994cited by this paper
• A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct.

  1994cited by this paper
• Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor‐β type II receptor family

  1993cited by this paper
• TGF beta signals through a heteromeric protein kinase receptor complex.

  1992cited by this paper
• Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.

  1992cited by this paper
• Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.

  1992cited by this paper
• The TGF-beta-related DVR gene family in mammalian development.

  1992cited by this paper
• Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

  1989cited by this paper
• Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells.

  1986cited by this paper
• Cloning and expression of cDNA for anti-müllerian hormone.

  1986cited by this paper
• The epithelial-mesenchymal interface of the male rate Mullerian duct: loss of basement membrane integrity and ductal regression.

  1982cited by this paper
• Programmed cell death in the Müllerian duct induced by Müllerian inhibiting substance.

  1977cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary*

  year unknowncited by this paper

• PCOS Influences the Expression of AMHRII in the Endometrium of AEH During the Reproductive Age

  2024cites this paper
• From Enrico Sertoli to freemartinism: the many phases of the master testis-determining cell

  2023cites this paper
• Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity

  2023cites this paper
• Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression

  2022cites this paper
• A transgenic bacterial artificial chromosome approach to identify regulatory regions that direct Amhr2 and Osterix expression in Müllerian duct mesenchyme

  2022cites this paper
• Physiological role and diagnostic value of anti-Mullerian hormone in pediatrics

  2022cites this paper
• Molecular Mechanisms of AMH Signaling

  2022cites this paper
• Fetal resorption coincides with dysregulated LH secretion in AMH-overexpressing mice.

  2022cites this paper
• Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival

  2021cites this paper
• Anti-mullerian hormone attenuates insulin resistance and systemic inflammation in old obese C57BL/6 male mice

  2021cites this paper
• Environmental Impacts on Male Reproductive Development: Lessons from Experimental Models

  2021cites this paper
• Clinical Utility of Anti-Mullerian Hormone in Pediatrics

  2021cites this paper
• Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment

  2021cites this paper
• Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-β family

  2021cites this paper
• Pathophysiological Bases for the Classification of the Human Sex Development Anomalies

  2021cites this paper
• Targeted Next-Generation Sequencing Indicates a Frequent Oligogenic Involvement in Primary Ovarian Insufficiency Onset

  2021cites this paper
• Disorders of Sex Development—Novel Regulators, Impacts on Fertility, and Options for Fertility Preservation

  2020cites this paper
• Mutational Analysis of the Putative Anti-Müllerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2

  2020cites this paper
• SEXUAL DIFFERENTIATION

  2020cites this paper
• Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility

  2019cites this paper
• Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.

  2019cites this paper
• Anti-Müllerian hormone : a look back and ahead.

  2019cites this paper
• The Role of Antimullerian Hormone in Assisted Reproduction

  2019cites this paper
• Ovarian hormones AMH and E2 in juvenile gilts as markers of reproductive success

  2019cites this paper
• [Mullerian inhibiting substance type II receptor as a potential target for antineoplastic therapy].

  2019cites this paper
• Anti-mullerian hormone receptor type II as a Potential Target for Antineoplastic Therapy

  2019cites this paper
• Association of Anti-Mullerian Hormone with C-Reactive Protein in Men

  2019cites this paper
• A gene regulatory network for Müllerian duct regression

  2019cites this paper
• ACVR1 Function in Health and Disease

  2019cites this paper
• The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility

  2019cites this paper
• The cell biology and molecular genetics of Müllerian duct development

  2018cites this paper
• Expression of Müllerian-Inhibiting Substance/Anti-Müllerian Hormone Type II Receptor in the Human Theca Cells

  2018cites this paper
• Anti-Müllerian hormone type II receptor in avian follicle development†

  2018cites this paper
• Female-to-male sex reversal in orange-spotted grouper (Epinephelus coioides) caused by overexpressing of Amh in vivo†

  2018cites this paper
• Anti‐Müllerian hormone signaling is influenced by Follistatin 288, but not 14 other transforming growth factor beta superfamily regulators

  2017influential citation
• Drosophila models of FOP provide mechanistic insight.

  2017influential citation
• The TGF-β Family in the Reproductive Tract.

  2017cites this paper
• The Use of Concentration of Anti-Mullerian Hormone (AMH) as an Indicator of Reproductive Performance in Livestock Species

  2017cites this paper
• INVESTIGATING THE REPRODUCTIVE ROLE OF ANTI-MULLERIAN HORMONE VIA ANTI-MULLERIAN HORMONE RECEPTOR, TYPE II IN THE HEN

  2017cites this paper
• A putative role for anti-Müllerian hormone (AMH) in optimising ovarian reserve expenditure.

  2017cites this paper
• Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.

  2016cites this paper
• Persistent Müllerian Duct Syndrome Caused by a Novel Mutation of an Anti-MüIlerian Hormone Receptor Gene: Case Presentation and Literature Review.

  2016cites this paper
• Male Reproductive Tract Development & Function Embryonic Development and Reproductive Tract Organogenesis-Overview-Development of Mullerian Duct vs. Duct Wolffian Duct Derivatives-Mullerian Inhibiting Substance (MIS) Male Urogenital Tract Organogenesis-Prevention of Programmed Cell Death in the Wolf

  2016cites this paper
• Is Anti-Müllerian hormone regulated by TGFbeta Superfamily Binding Proteins?

  2016cites this paper
• Challenging the Dogma of Canonical BMP signaling in the absence of Smad4 during Endochondral Bone Formation

  2016cites this paper
• Partial Müllerian Duct Retention in Smad4 Conditional Mutant Male Mice

  2016cites this paper
• Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.

  2016cites this paper
• A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Müllerian hormone signaling pathway.

  2016cites this paper
• Constitutive negative regulation in the processing of the anti-Müllerian hormone receptor II

  2015cites this paper
• TGFβ (transforming growth factor β) superfamily members and their receptors in the fetal porcine ovaries: effect of prenatal flutamide treatment.

  2015cites this paper
• The Type I BMP Receptor ACVR1/ALK2 is Required for Chondrogenesis During Development

  2015cites this paper
• Multi‐system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients

  2015cites this paper
• Pathogenesis and Aetiology of Female Genital Malformations

  2015cites this paper
• AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer

  2015influential citation
• Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors

  2014cites this paper
• Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.

  2014cites this paper
• Protein associated with SMAD1 (PAWS1/FAM83G) is a substrate for type I bone morphogenetic protein receptors and modulates bone morphogenetic protein signalling

  2014cites this paper
• Etude de nouveaux facteurs moléculaires régulant la migration de neurones à GnRH, leur ciblage axonales et leur neurosécrétion : aperçues dans l'acquisition de la compétence reproductive

  2014cites this paper
• Analyse comparative, physiologique et moléculaire des effets de trois traitements masculinisants chez le tilapia du Nil, Oreochromis niloticus, et recherche de marqueurs de traçabilité liés à ces approches

  2014cites this paper
• Voie de signalisation et gènes cibles de l’AMH dans le tractus génital femelle

  2014cites this paper
• Anti-Müllerian Hormone Recruits BMPR-IA in Immature Granulosa Cells

  2013cites this paper
• Anti-Müllerian Hormone: A Valuable Addition to the Toolbox of the Pediatric Endocrinologist

  2013cites this paper
• Regulation of ovarian function: structural characterization and role of anti-Müllerian hormone (AMH).

  2013cites this paper
• Dissecting the molecular mechanisms of the TGF-ß/BMP signal transduction pathways : mapping new players and critically assessing established tools

  2013cites this paper
• Hyperactive BMP signaling induced by ALK2R206H requires type II receptor function in a Drosophila model for classic fibrodysplasia ossificans progressiva

  2012cites this paper
• The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling.

  2012cites this paper
• Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.

  2012cites this paper
• Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance

  2012influential citation
• The role of anti-Mullerian hormone in the differentiation, development, and functioning of the reproductive system

  2011cites this paper
• Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.

  2011cites this paper
• TGF-β superfamily: how does it regulate testis development

  2011cites this paper
• Current Understanding of Mullerian-Inhibiting Substance

  2011cites this paper
• Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.

  2010cites this paper
• Focal Müllerian duct retention in male mice with constitutively activated β-catenin expression in the Müllerian duct mesenchyme

  2010cites this paper
• Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

  2010cites this paper
• Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.

  2010cites this paper
• Sex differentiation in mouse and man and subsequent development of the female reproductive organs

  2010cites this paper
• The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.

  2009cites this paper
• The Role of Genes in the Development of Mullerian Anomalies: Where Are We Today?

  2009influential citation
• The developing female genital tract: from genetics to epigenetics.

  2009cites this paper
• Bone morphogenetic proteins in orthopaedic surgery.

  2009cites this paper
• Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.

  2009cites this paper
• Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.

  2009cites this paper
• Negative Regulation of the TGF-β Family Signal Pathway by Inhibitory Smads and Their Involvement in Cancer and Fibrosis

  2008cites this paper
• Localization of Mullerian inhibiting substance receptors in various human cancer cell lines

  2008cites this paper
• Mouse Dach1 and Dach2 are redundantly required for Müllerian duct development

  2008cites this paper
• Pyrazoloanthrone et dérivés de celle-ci pour le traitement du cancer et d'états avec excès d'androgène

  2008cites this paper
• Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.

  2008influential citation
• SMAD expression in the testis: An insight into BMP regulation of spermatogenesis

  2008influential citation
• A mesenchymal perspective of müllerian duct differentiation and regression in Amhr2‐lacZ mice

  2008cites this paper
• c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.

  2008cites this paper
• Mullerian Inhibiting Substance: A Potential Nontoxic, Naturally Occurring Therapeutic Agent for Certain Human Cancers

  2008cites this paper
• Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometrium.

  2007cites this paper
• Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.

  2007influential citation
• Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.

  2007cites this paper
• Development of a sexually differentiated behavior and its underlying CNS arousal functions.

  2007cites this paper
• Effects of growth factors on testicular morphogenesis.

  2007cites this paper
• The Müllerian Duct: Recent Insights into Its Development and Regression

  2007cites this paper
• The Role of Vitamin D Stimulation of Mullerian Inhibiting Substance (MIS) in Prostate Cancer Therapy

  2007cites this paper
• Activins and Leydig Cell Development Differentiation, and Disease

  2007cites this paper